X4 Pharmaceuticals to Participate in Upcoming November Investor Conferences

Rhea-AI Summary

X4 Pharmaceuticals (XFOR) to participate in fireside chats at Stifel Healthcare Conference on November 14-15, 2023, and Piper Sandler 35th Annual Healthcare Conference on November 28-30, 2023. The management will engage in discussions about the company's initiatives in rare diseases of the immune system, emphasizing its commitment to improving patients' lives. Webcast links provided for both events.

BOSTON, Nov. 10, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that management will be participating in fireside chats at the upcoming Stifel Healthcare Conference being held in New York City, from November 14-15, 2023, and the Piper Sandler 35^th Annual Healthcare Conference being held in New York City, from November 28-30, 2023.

Stifel Healthcare Conference
Date: Tuesday, November 14, 2023
Time: 4:10 PM ET
Webcast Link

Piper Sandler 35^th Annual Healthcare Conference
Date: Tuesday, November 28, 2023
Time: 1:00PM ET
Webcast Link

About X4 Pharmaceuticals
X4 Pharmaceuticals is a late-stage clinical biopharmaceutical company driven to improve the lives of people with rare diseases of the immune system. Our lead clinical candidate is mavorixafor, a small molecule antagonist of chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy across a variety of immunodeficiencies, including WHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) syndrome and certain chronic neutropenic disorders. Following successful completion of a global, pivotal, Phase 3 clinical trial, we are seeking U.S. regulatory approval of oral, once-daily mavorixafor for the treatment of people aged 12 years and older with WHIM syndrome. We are also currently planning a Phase 3 clinical program evaluating mavorixafor in certain chronic neutropenic disorders. We continue to leverage our insights into CXCR4 and immune system biology at our corporate headquarters in Boston, Massachusetts and at our research center of excellence in Vienna, Austria. For more information, please visit our website at www.x4pharma.com.

Contacts:
Daniel Ferry (investors)
Managing Director, LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576

Brett Whelan (media)
LifeSci Communications
bwhelan@lifescicomms.com

FAQ

What events will X4 Pharmaceuticals be participating in?

X4 Pharmaceuticals will be participating in the Stifel Healthcare Conference on November 14-15, 2023, and the Piper Sandler 35th Annual Healthcare Conference on November 28-30, 2023.

What is the focus of the discussions at the conferences?

The discussions will revolve around the company's initiatives in rare diseases of the immune system and its commitment to improving patients' lives.

Where will the conferences be held?

The Stifel Healthcare Conference and the Piper Sandler 35th Annual Healthcare Conference will both be held in New York City.

When will the fireside chats take place?

The fireside chat at the Stifel Healthcare Conference will take place on Tuesday, November 14, 2023, at 4:10 PM ET, and the one at the Piper Sandler 35th Annual Healthcare Conference will take place on Tuesday, November 28, 2023, at 1:00 PM ET.